Physician

Jameson Travis Mendel, MD

According to 2025 Medicare claims, Jameson Mendel, MD (NPI: 1679952915) practices radiation oncology in the El Paso, TX market, with the plurality of this provider's patient population coming from El Paso, TX. This provider's primary affiliated billing organization is RIO GRANDE UROLOGY PA (NPI: 1750416921; TIN: 611519241) and primary practice location at 79912-3537.

Mendel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 644 traditional Medicare patients, billed 18,920 HCPCS/CPT codes, and received $1,895,067 in Medicare payments. The top billing code was 74178 (Ct scan of abdomen and pelvis before and after contrast). Part D data shows 1,939 prescription claims across 473 beneficiaries totaling $24,186 in drug costs, led by Myrbetriq (Mirabegron). 2023 DME data shows 12 claims. Open Payments data shows 88 records totaling $10,309. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $448 and ending at $24,186. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	246	3,924	$440,463
2021	699	11,786	$1,675,461
2022	656	20,319	$2,048,989
2023	640	17,116	$1,738,126
2024	644	18,920	$1,895,067

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	18	$448
2016	12	22	$682
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	116	251	$102,295
2021	377	1,548	$283,375
2022	447	1,824	$73,639
2023	476	2,087	$101,872
2024	473	1,939	$24,186

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$143,843
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
74178	Ct scan of abdomen and pelvis before and after contrast	131	135	$261
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	131	202	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	136	188	$13
36415	Insertion of needle into vein for collection of blood sample	236	261	$9
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	174	182	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	21	885	$13,471
Tamsulosin Hcl	Tamsulosin Hcl	312	17,531	$3,260
Ciprofloxacin Hcl	Ciprofloxacin Hcl	352	1,342	$1,270
Dexamethasone	Dexamethasone	350	405	$520
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	300	375	$496

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$10,111	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$198	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jameson Travis Mendel, MD?

Tedicare shows public-source Medicare data for Jameson Travis Mendel, MD (NPI 1679952915), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jameson Travis Mendel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jameson Travis Mendel, MD?

Jameson Travis Mendel, MD is linked to RIO GRANDE UROLOGY PA (billing NPI 1750416921) in the available physician profile data.

Does Jameson Travis Mendel, MD have Open Payments data?

Jameson Travis Mendel, MD has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.